menu
    • menu

    Company profile for Agenus

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Agenus is an immuno-oncology company designed to deliver innovation with speed for patients with cancer. We have a unique portfolio of antibodies, vaccines, cell therapies (through our AgenTus Therapeutics subsidiary) and adjuvants designed to treat cancers with optimal combinations. In addition to our broad portfolio, we have an accomplished team of scientists, novel technology platforms and end-to-end capabilities from new t...
    Agenus is an immuno-oncology company designed to deliver innovation with speed for patients with cancer. We have a unique portfolio of antibodies, vaccines, cell therapies (through our AgenTus Therapeutics subsidiary) and adjuvants designed to treat cancers with optimal combinations. In addition to our broad portfolio, we have an accomplished team of scientists, novel technology platforms and end-to-end capabilities from new target discovery to GMP manufacturing.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AgenusUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3 Forbes Road Lexington, MA 02421-7305
    Telephone
    Telephone
    781.674.4400
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://agenusbio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/agenus
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/hashtag/agenus?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Agenus Hosts End-Of-Year Webcast On GI Oncology Progress
    Agenus Hosts End-Of-Year Webcast On GI Oncology Progress

    19 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251119991532/en/Agenus-to-Host-End-of-Year-Stakeholder-Webcast-Featuring-GI-Oncology-Leaders-and-Progress-of-BOTBAL

    BUSINESSWIRE
    19 Nov 2025
    Share Share
    Agenus Appoints Dr. José Iglesias Chief Medical Affairs Officer
    Agenus Appoints Dr. José Iglesias Chief Medical Affairs Officer

    18 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251118089134/en/Agenus-Appoints-Dr.-Jos-Iglesias-as-Chief-Medical-Affairs-Officer-to-Guide-Global-Medical-Affairs-and-Early-Access-Programs-Including-Frances-AAC

    BUSINESSWIRE
    18 Nov 2025
    Share Share
    Agenus Highlights Clinical & Regulatory Progress In Q3 2025
    Agenus Highlights Clinical & Regulatory Progress In Q3 2025

    10 Nov 2025

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20251110256353/en/Agenus-Reports-Q3-2025-Results-Showcasing-Clinical-and-Regulatory-Advances

    BUSINESS WIRE
    10 Nov 2025
    Share Share
    Agenus Provides Corporate Update & Q3 2025 Financial Report
    Agenus Provides Corporate Update & Q3 2025 Financial Report

    05 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251105810151/en/Agenus-to-Provide-Corporate-Update-and-Third-Quarter-2025-Financial-Report

    BUSINESSWIRE
    05 Nov 2025
    Share Share
    Agenus Reveals 39% Two-Year Survival Rate With BOT/BAL Tumors
    Agenus Reveals 39% Two-Year Survival Rate With BOT/BAL Tumors

    17 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251017753429/en/Agenus-Reports-39-of-Patients-Alive-at-Two-Years-with-BOTBAL-Across-Multiple-Refractory-Solid-Tumors-at-ESMO-2025

    BUSINESSWIRE
    17 Oct 2025
    Share Share
    Agenus Showcases BOT/BAL Global Momentum In October Stakeholder
    Agenus Showcases BOT/BAL Global Momentum In October Stakeholder

    16 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251016147598/en/Agenus-to-Host-October-Stakeholder-Briefing-Showcasing-BOTBAL-Global-Momentum-and-Post-ESMO-Insights

    BUSINESSWIRE
    16 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search